vimarsana.com

Page 13 - Development Portfolio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astra Energy Inc Provides Shareholder Update

Prologis Reports Fourth Quarter and Full Year 2023 Results

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Application (NDA) submission to the FDA planned for the second half of 2024 In Japan, China and most countries in Europe cyclobenzaprine is a New Chemical Entity CHATHAM, N.J., March 12, 2024 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of developme

Ten63 Therapeutics Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim

/PRNewswire/ Ten63 Therapeutics, a biotechnology company unlocking previously undruggable targets by leveraging proprietary algorithms combining.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.